McKesson (MCK) Q2 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 11/06/25
McKesson Corporation Reports Fiscal 2026 Second Quarter Results and Raises Full Year Adjusted EPS GuidanceBusiness Wire • 11/05/25
Ahead of McKesson (MCK) Q2 Earnings: Get Ready With Wall Street Estimates for Key MetricsZacks Investment Research • 10/31/25
4 Resilient Dental Supply Players Positioned to Withstand Tariff RisksZacks Investment Research • 10/31/25
McKesson (MCK) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 10/29/25
McKesson (MCK) Upgraded to Strong Buy: Here's What You Should KnowZacks Investment Research • 10/28/25
McKesson (MCK) Surpasses Market Returns: Some Facts Worth KnowingZacks Investment Research • 10/24/25
McKesson Corporation Transforming Towards High-Margin Operations: Why I Choose To BuySeeking Alpha • 10/11/25
McKesson: Strategic Shift To High-Growth Oncology And Prescription Tech Signals Long OpportunitySeeking Alpha • 10/11/25
McKesson Corporation Highlights Strategic Growth Strategies and Unveils Updated Long-term Financial Targets at Investor DayBusiness Wire • 09/23/25
Drug distributor McKesson to restructure segments to focus on high-margin businessesReuters • 09/18/25